CHMP meeting highlights – December 2022
A total of five drugs were recommended for approval at the CHMP’s December meeting, including a gene therapy and two cancer drugs.
List view / Grid view
A total of five drugs were recommended for approval at the CHMP’s December meeting, including a gene therapy and two cancer drugs.
Ten medicines have been recommended for marketing authorisation and 10 extensions of indication have been suggested by the EMA.
The EMA has given its approval recommendation to three drugs and announced negative opinions for approval on others.